The injectable cement market size has grown strongly in recent years. It will grow from $1.55 billion in 2025 to $1.66 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increasing incidence of bone fractures, reliance on traditional orthopedic fixation methods, growing elderly population, expansion of hospital-based orthopedic care, adoption of PMMA-based bone cements.
The injectable cement market size is expected to see strong growth in the next few years. It will grow to $2.13 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to technological advancements in injectable cement formulations, rising demand for minimally invasive surgeries, increasing orthopedic trauma cases, growth in outpatient and clinic-based procedures, higher focus on biocompatible and bioactive materials. Major trends in the forecast period include rising adoption of minimally invasive orthopedic procedures, growing use of injectable cement in fracture stabilization, increasing preference for image-guided cement injection, advancements in bioactive and composite injectable cements, improved focus on faster recovery and patient outcomes.
The increasing number of sports-related injuries is increasingly supporting the expansion of the injectable cement market going forward. Sports-related injuries include physical damage such as fractures, sprains, strains, and joint injuries sustained during athletic activities. The rise in sports-related injuries is associated with greater participation in sports, more intensive training programs, and increased physical demands placed on athletes. Injectable cement is used to stabilize fractures, support bone healing, and improve surgical outcomes by offering a minimally invasive and effective solution for bone reinforcement. For example, in July 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, cycling accounted for approximately 12% of sports-related hospitalizations in 2023-24, followed by Australian rules football and soccer. As a result, the growing number of sports-related injuries is contributing to the expansion of the injectable cement market.
Leading companies operating in the injectable cement market are focusing on technological advancements such as antibiotic-loaded bone cement to enhance infection control, improve patient outcomes, and support more targeted orthopedic treatments. Antibiotic-loaded bone cement is a specialized bone cement formulation containing antibiotics to help prevent or manage infections at surgical sites, particularly in orthopedic procedures. For example, in April 2024, Heraeus Medical GmbH, a Germany-based medical technology manufacturer, launched COPAL G+C, its latest antibiotic-loaded bone cement and the company’s first product certified under the Medical Device Regulation (MDR). COPAL G+C combines gentamicin and clindamycin, enabling targeted infection management in arthroplasty by addressing up to 90% of pathogens commonly linked to prosthetic joint infections.
In September 2023, Globus Medical Inc., a US-based provider of musculoskeletal solutions, including orthopedic cement, merged with NuVasive Inc. for an undisclosed amount. This merger is intended to reinforce its position in spinal surgery technologies, enhance its ability to deliver innovative minimally invasive solutions, and drive market growth. NuVasive Inc. is a US-based medical device company offering spinal treatment solutions, including injectable bone cement.
Major companies operating in the injectable cement market are Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc, Smith & Nephew, Arthrex Inc, Enovis Corporation, Globus Medical Inc, Wright Medical Group N.V, Medacta International, Orthofix Medical Inc, Alphatec Spine Inc, Exactech Inc, Spine Wave Inc, Tecres SpA, Heraeus Medical GmbH, TEKNIMED, Graftys SA, Solco Biomedical, Terumo Corporation, Bonesupport AB, Peregrine Biologics, aap Implantate AG, Biometrix Ltd, OSARTIS GmbH, IZI Medical.
North America was the largest region in the injectable cement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the injectable cement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the injectable cement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the injectable cement market by increasing the cost of imported raw materials such as polymers, bioactive compounds, and specialized packaging. High and medium viscosity cement segments are particularly affected, with regions like Asia-Pacific and Europe experiencing pricing pressure due to import duties. These cost increases have influenced procurement decisions for hospitals and clinics. However, tariffs have also encouraged local manufacturing, supply chain diversification, and innovation in cost-effective cement formulations, supporting long-term market sustainability.
The injectable cement market research report is one of a series of new reports that provides injectable cement market statistics, including injectable cement industry global market size, regional shares, competitors with a injectable cement market share, detailed injectable cement market segments, market trends and opportunities, and any further data you may need to thrive in the injectable cement industry. This injectable cement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Injectable cement is a bone cement used in orthopedic procedures to stabilize fractures, support implants, or fill bone defects. It is injected under imaging guidance for precise placement, enabling minimally invasive treatment and immediate stabilization to improve patient recovery.
The main categories of injectable cement include high-viscosity cement, low-viscosity cement, and medium-viscosity cement. High-viscosity cement has a thicker consistency, resulting in reduced fluidity while offering enhanced stability after hardening, making it suitable for applications requiring strong and long-lasting fixation, such as high-load fractures or complex joint replacement procedures. The applications include periprosthetic fractures, pelvic fractures, and others, and the end users include hospitals, clinics, and others.
The injectable cement market consists of sales of antibiotic-loaded bone cements, calcium phosphate cements, customizable injectable cement, and bioactive glass cement. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The injectable cement market size is expected to see strong growth in the next few years. It will grow to $2.13 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to technological advancements in injectable cement formulations, rising demand for minimally invasive surgeries, increasing orthopedic trauma cases, growth in outpatient and clinic-based procedures, higher focus on biocompatible and bioactive materials. Major trends in the forecast period include rising adoption of minimally invasive orthopedic procedures, growing use of injectable cement in fracture stabilization, increasing preference for image-guided cement injection, advancements in bioactive and composite injectable cements, improved focus on faster recovery and patient outcomes.
The increasing number of sports-related injuries is increasingly supporting the expansion of the injectable cement market going forward. Sports-related injuries include physical damage such as fractures, sprains, strains, and joint injuries sustained during athletic activities. The rise in sports-related injuries is associated with greater participation in sports, more intensive training programs, and increased physical demands placed on athletes. Injectable cement is used to stabilize fractures, support bone healing, and improve surgical outcomes by offering a minimally invasive and effective solution for bone reinforcement. For example, in July 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, cycling accounted for approximately 12% of sports-related hospitalizations in 2023-24, followed by Australian rules football and soccer. As a result, the growing number of sports-related injuries is contributing to the expansion of the injectable cement market.
Leading companies operating in the injectable cement market are focusing on technological advancements such as antibiotic-loaded bone cement to enhance infection control, improve patient outcomes, and support more targeted orthopedic treatments. Antibiotic-loaded bone cement is a specialized bone cement formulation containing antibiotics to help prevent or manage infections at surgical sites, particularly in orthopedic procedures. For example, in April 2024, Heraeus Medical GmbH, a Germany-based medical technology manufacturer, launched COPAL G+C, its latest antibiotic-loaded bone cement and the company’s first product certified under the Medical Device Regulation (MDR). COPAL G+C combines gentamicin and clindamycin, enabling targeted infection management in arthroplasty by addressing up to 90% of pathogens commonly linked to prosthetic joint infections.
In September 2023, Globus Medical Inc., a US-based provider of musculoskeletal solutions, including orthopedic cement, merged with NuVasive Inc. for an undisclosed amount. This merger is intended to reinforce its position in spinal surgery technologies, enhance its ability to deliver innovative minimally invasive solutions, and drive market growth. NuVasive Inc. is a US-based medical device company offering spinal treatment solutions, including injectable bone cement.
Major companies operating in the injectable cement market are Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc, Smith & Nephew, Arthrex Inc, Enovis Corporation, Globus Medical Inc, Wright Medical Group N.V, Medacta International, Orthofix Medical Inc, Alphatec Spine Inc, Exactech Inc, Spine Wave Inc, Tecres SpA, Heraeus Medical GmbH, TEKNIMED, Graftys SA, Solco Biomedical, Terumo Corporation, Bonesupport AB, Peregrine Biologics, aap Implantate AG, Biometrix Ltd, OSARTIS GmbH, IZI Medical.
North America was the largest region in the injectable cement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the injectable cement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the injectable cement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the injectable cement market by increasing the cost of imported raw materials such as polymers, bioactive compounds, and specialized packaging. High and medium viscosity cement segments are particularly affected, with regions like Asia-Pacific and Europe experiencing pricing pressure due to import duties. These cost increases have influenced procurement decisions for hospitals and clinics. However, tariffs have also encouraged local manufacturing, supply chain diversification, and innovation in cost-effective cement formulations, supporting long-term market sustainability.
The injectable cement market research report is one of a series of new reports that provides injectable cement market statistics, including injectable cement industry global market size, regional shares, competitors with a injectable cement market share, detailed injectable cement market segments, market trends and opportunities, and any further data you may need to thrive in the injectable cement industry. This injectable cement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Injectable cement is a bone cement used in orthopedic procedures to stabilize fractures, support implants, or fill bone defects. It is injected under imaging guidance for precise placement, enabling minimally invasive treatment and immediate stabilization to improve patient recovery.
The main categories of injectable cement include high-viscosity cement, low-viscosity cement, and medium-viscosity cement. High-viscosity cement has a thicker consistency, resulting in reduced fluidity while offering enhanced stability after hardening, making it suitable for applications requiring strong and long-lasting fixation, such as high-load fractures or complex joint replacement procedures. The applications include periprosthetic fractures, pelvic fractures, and others, and the end users include hospitals, clinics, and others.
The injectable cement market consists of sales of antibiotic-loaded bone cements, calcium phosphate cements, customizable injectable cement, and bioactive glass cement. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Injectable Cement Market Characteristics
3. Injectable Cement Market Supply Chain Analysis
4. Global Injectable Cement Market Trends and Strategies
5. Injectable Cement Market Analysis of End Use Industries
7. Global Injectable Cement Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Injectable Cement Total Addressable Market (TAM) Analysis for the Market
9. Injectable Cement Market Segmentation
10. Injectable Cement Market Regional and Country Analysis
11. Asia-Pacific Injectable Cement Market
12. China Injectable Cement Market
13. India Injectable Cement Market
14. Japan Injectable Cement Market
15. Australia Injectable Cement Market
16. Indonesia Injectable Cement Market
17. South Korea Injectable Cement Market
18. Taiwan Injectable Cement Market
19. South East Asia Injectable Cement Market
20. Western Europe Injectable Cement Market
21. UK Injectable Cement Market
22. Germany Injectable Cement Market
23. France Injectable Cement Market
24. Italy Injectable Cement Market
25. Spain Injectable Cement Market
26. Eastern Europe Injectable Cement Market
27. Russia Injectable Cement Market
28. North America Injectable Cement Market
29. USA Injectable Cement Market
30. Canada Injectable Cement Market
31. South America Injectable Cement Market
32. Brazil Injectable Cement Market
33. Middle East Injectable Cement Market
34. Africa Injectable Cement Market
36. Injectable Cement Market Competitive Landscape and Company Profiles
37. Injectable Cement Market Other Major and Innovative Companies
40. Injectable Cement Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Injectable Cement Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses injectable cement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for injectable cement? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The injectable cement market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: High Viscosity Cement; Low Viscosity Cement; Medium Viscosity Cement2) By Application: Periprosthetic Fractures; Pelvic Fractures; Other Applications
3) By End User: Hospital; Clinics; Other End Users
Subsegments:
1) By High Viscosity Cement: Calcium Phosphate Cements; Polymethyl Methacrylate (PMMA) Cements2) By Low Viscosity Cement: Acrylic-Based Injectable Cements; Bioactive Glass Cements
3) By Medium Viscosity Cement: Hybrid Injectable Cements; Composite Injectable Cements
Companies Mentioned: Johnson & Johnson; Stryker Corporation; Zimmer Biomet Holdings Inc; Smith & Nephew; Arthrex Inc; Enovis Corporation; Globus Medical Inc; Wright Medical Group N.V; Medacta International; Orthofix Medical Inc; Alphatec Spine Inc; Exactech Inc; Spine Wave Inc; Tecres SpA; Heraeus Medical GmbH; TEKNIMED; Graftys SA; Solco Biomedical; Terumo Corporation; Bonesupport AB; Peregrine Biologics; aap Implantate AG; Biometrix Ltd; OSARTIS GmbH; IZI Medical
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Injectable Cement market report include:- Johnson & Johnson
- Stryker Corporation
- Zimmer Biomet Holdings Inc
- Smith & Nephew
- Arthrex Inc
- Enovis Corporation
- Globus Medical Inc
- Wright Medical Group N.V
- Medacta International
- Orthofix Medical Inc
- Alphatec Spine Inc
- Exactech Inc
- Spine Wave Inc
- Tecres SpA
- Heraeus Medical GmbH
- TEKNIMED
- Graftys SA
- Solco Biomedical
- Terumo Corporation
- Bonesupport AB
- Peregrine Biologics
- aap Implantate AG
- Biometrix Ltd
- OSARTIS GmbH
- IZI Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.66 Billion |
| Forecasted Market Value ( USD | $ 2.13 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
